In AD there is impairment of the skin barrier, and keratinocytes have been found to express decreased amounts of skin barrier proteins, such as filaggrin, loricrin, and involucrin, which may result in increased permeability to allergens and topically administered drugs 38. The gene discussed is LORICRIN; the disease is Alzheimer disease.